Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Rodrigues

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Bulletin Du Cancer|September 2, 2023
Real-world dostarlimab use in advanced/recurrent endometrial cancer in FranceManuel Rodrigues, Lauriane Eberst, Philippe Follana, et al.
Bulletin Du Cancer|December 23, 2017
[Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer]Stéphane Vignot, Thierry André, Christophe Caux, et al.
Melanoma Management|January 27, 2025
Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trialSophie Piperno-Neumann, Leanne de Koning, Timothée Marchal, et al.
Nature Communications|July 2, 2025
Author Correction: Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomesAndré Bortolini Silveira, Alexandre Houy, Olivier Ganier, et al.
JAMA Ophthalmology|January 3, 2020
Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free SurvivalManuel Rodrigues, Khadija Ait Rais, Flore Salviat, et al.
Cancers|May 16, 2023
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal MelanomaMalcy Tarin, Fariba Némati, Didier Decaudin, et al.
Nature Communications|November 14, 2024
Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomesAndré Bortolini Silveira, Alexandre Houy, Olivier Ganier, et al.
Journal of the National Cancer Institute|August 23, 2021
Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal MelanomasLenha Mobuchon, Anne-Céline Derrien, Alexandre Houy, et al.
JAMA Oncology|October 27, 2022
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Journal of the National Cancer Institute|April 3, 2020
Germline MBD4 Mutations and Predisposition to Uveal MelanomaAnne-Céline Derrien, Manuel Rodrigues, Alexandre Eeckhoutte, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Bulletin Du Cancer|September 2, 2023
Real-world dostarlimab use in advanced/recurrent endometrial cancer in FranceManuel Rodrigues, Lauriane Eberst, Philippe Follana, et al.
Bulletin Du Cancer|December 23, 2017
[Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer]Stéphane Vignot, Thierry André, Christophe Caux, et al.
Melanoma Management|January 27, 2025
Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trialSophie Piperno-Neumann, Leanne de Koning, Timothée Marchal, et al.
Nature Communications|July 2, 2025
Author Correction: Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomesAndré Bortolini Silveira, Alexandre Houy, Olivier Ganier, et al.
JAMA Ophthalmology|January 3, 2020
Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free SurvivalManuel Rodrigues, Khadija Ait Rais, Flore Salviat, et al.
Cancers|May 16, 2023
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal MelanomaMalcy Tarin, Fariba Némati, Didier Decaudin, et al.
Nature Communications|November 14, 2024
Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomesAndré Bortolini Silveira, Alexandre Houy, Olivier Ganier, et al.
Journal of the National Cancer Institute|August 23, 2021
Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal MelanomasLenha Mobuchon, Anne-Céline Derrien, Alexandre Houy, et al.
JAMA Oncology|October 27, 2022
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
Journal of the National Cancer Institute|April 3, 2020
Germline MBD4 Mutations and Predisposition to Uveal MelanomaAnne-Céline Derrien, Manuel Rodrigues, Alexandre Eeckhoutte, et al.
Pageof 20